Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

ESSA Pharma Inc

EPIX
Current price
1.62 USD -0.01 USD (-0.61%)
Last closed 1.63 USD
ISIN CA29668H7085
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 72 353 416 USD
Yield for 12 month -82.20 %
1Y
3Y
5Y
10Y
15Y
EPIX
21.11.2021 - 28.11.2021

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company's lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer. It has collaboration agreements with Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada. Address: 999 West Broadway, Vancouver, BC, Canada, V5Z 1K5

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

9.25 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-118 491 USD

Last Year

-121 787 USD

Current Quarter

-22 665 USD

Last Quarter

-15 504 USD

Key Figures EPIX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -23 501 624 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -14.79 %
PEG Ratio
Return On Equity TTM -19.83 %
Wall Street Target Price 9.25 USD
Revenue TTM
Book Value 2.90 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.62 USD
Diluted Eps TTM -0.62 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics EPIX

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History EPIX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor 1:20
Payout Ratio
Last Split Date 25.04.2018

Stock Valuation EPIX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -8.09
Price Book MRQ 0.56

Financials EPIX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators EPIX

For 52 weeks

1.40 USD 11.67 USD
50 Day MA 3.35 USD
Shares Short Prior Month 726 535
200 Day MA 5.59 USD
Short Ratio 0.32
Shares Short 691 472
Short Percent 2.59 %